^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    EFNB2 positive

    i
    Other names: EFNB2, Ephrin B2, HTK Ligand, Ephrin-B2, LERK5, HTKL, Eph-Related Receptor Tyrosine Kinase Ligand 5, Ligand Of Eph-Related Kinase 5, EPLG5, Htk-L, EPH-Related Receptor Tyrosine Kinase Ligand 5, MGC126226, MGC126227, MGC126228, LERK-5, EFNB2, HTK-L
    Entrez ID:
    1948
    Related biomarkers:
    Expression
    over1year
    EphrinB2: Expression of a novel potential target in renal cell carcinoma. (PubMed, Indian J Urol)
    EphrinB2 is expressed in approximately half of RCC cases. EphrinB2 expression in the early stage cancer might indicate its induction as an early event.
    Journal
    |
    EPHB4 (EPH receptor B4)
    |
    EFNB2 positive • EFNB2 expression